Syner-Med Syner-Med is a company dedicated to the development and marketing of pharmaceutical products, medical devices as well as licensing. | ![]() ZAI Lab Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases. | ![]() Photocure Photocure engages in the research, development, production, distribution of pharmaceutical products and related technical medical equipment. | ![]() Medexus Pharma Medexus Pharma is a pharmaceutical company developing therapies for autoimmune diseases and cancer. | |
Founding Date | Founding Date 1995 | Founding Date 2014 | Founding Date 1997 | Founding Date 2012 |
Type | Type Private | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Purley, GB HQ Teteringen, NL | Locations CN HQ Suzhou, CN Hong Kong, HK Taipei, TW Cambridge, US Menlo Park, US | Locations Ullern, NO HQ Düsseldorf, DE Princeton, US | Locations Chicago, US HQ |
Employees | Employees 18 | Employees 1,869 | Employees 99 | Employees 106 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 3.2 b | Valuation ($) 127.5 m | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $460.2m (FY, 2025) | Revenue (est.) kr532.6m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $190.5m (FY, 2025) | Cost of goods kr29.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $269.6m (FY, 2025) | Gross profit kr503.4m (FY, 2025) | Gross profit N/A |
Net income | Net income N/A | Net income ($175.5m) (FY, 2025) | Net income (kr1.5m) (FY, 2025) | Net income N/A |

Zai Lab is a biopharmaceutical company dedicated to discovering, developing, and commercializing medicines for cancer, autoimmune and infectious diseases.
View company
Photocure engages in the research, development, production, distribution of pharmaceutical products and related technical medical equipment.
View company
Medexus Pharma is a pharmaceutical company developing therapies for autoimmune diseases and cancer.
View company